Clinical Trial Update: Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluated hypofractionated radiation therapy for high-risk prostate cancer features after radical prostatectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8 | Phase 2 | Status: COMPLETED